These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18424)

  • 21. [Therapy of cardiomyopathies].
    Pflederer W
    Fortschr Med; 1982 Aug; 100(31-32):1440-7. PubMed ID: 6127295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated use of digitalis and nitrates in the elderly.
    Goldsmith SR; Marx S
    Geriatrics; 1988 Jan; 43(1):71-2, 75, 78-82 passim. PubMed ID: 2891589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 24. [Disputable problems concerning the use of certain methods of treatment of cardiovascular diseases].
    Chazov EI
    Ter Arkh; 1975; 47(5):33-44. PubMed ID: 240212
    [No Abstract]   [Full Text] [Related]  

  • 25. [The value of drug therapy in coronary disease].
    Stauch M
    ZFA (Stuttgart); 1979 Oct; 55(28):1577. PubMed ID: 44408
    [No Abstract]   [Full Text] [Related]  

  • 26. [Physiopathology and drug therapy of coronary insufficiency].
    Wink K
    Med Monatsschr Pharm; 1980 Oct; 3(10):294-301. PubMed ID: 6110164
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
    Grujić M; Perinović M
    Med Arh; 1972; 26(4):267-70. PubMed ID: 4405711
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug therapy of ischemic heart disease in ambulatory practice].
    Duck HJ; Trenckmann H; Fleischmann HJ; Neugebauer A; Schauer J
    Z Gesamte Inn Med; 1974 Nov; 29(22):932-6. PubMed ID: 4156817
    [No Abstract]   [Full Text] [Related]  

  • 29. Antianginal drugs.
    Kaverina NV; Chumburidze VB
    Pharmacol Ther; 1979; 4(1):109-53. PubMed ID: 88742
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the clinical use of a new drug in the therapy of coronary insufficiency].
    Bracchetti D; Spada E
    G Clin Med; 1966 Dec; 47(12):1261-82. PubMed ID: 4173047
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molsidomin compared to nitrates. Use in patients with manifest coronary disease].
    Lehmann HU; Brix W; Hochrein H
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1149-51. PubMed ID: 40120
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of chronic ischemic heart disease in a public assistance hospital].
    Freitag M; Heinrich HG
    Z Arztl Fortbild (Jena); 1979 Oct; 73(19-20):894-5. PubMed ID: 45158
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient.
    Wenger NK
    Cardiovasc Clin; 1985; 15(2):133-43. PubMed ID: 2868791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of calcium antagonists in the therapy of coronary heart disease].
    Meyer J
    Internist (Berl); 1983 Jul; 24(7):408-14. PubMed ID: 6136492
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 36. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preoperative treatment of coronaropathics. Etiopathogenetic, clinical and diagnostic aspects].
    Valenti B; Cernetti C; Baiocchi P
    Clin Ter; 1969 Jul; 50(1):57-74. PubMed ID: 4393971
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs and the heart. VII. Which drug for which disease?
    Opie LH
    Lancet; 1980 May; 1(8176):1011-7. PubMed ID: 6103335
    [No Abstract]   [Full Text] [Related]  

  • 39. [Beta-blocking drugs in coronary insufficiency. Clinical experiences with iproveratril].
    Guadagno L; Giannelli G; Ghiara F; Guadagno P; Zucchelli GP
    Minerva Med; 1967 Sep; 58(77):3288-94. PubMed ID: 6054782
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combined effect of beta-adrenoblockaders with other pharmacologic agents (review of the literature)].
    Gorodinskaia VIa
    Vrach Delo; 1971 Apr; 7():4-9. PubMed ID: 4400881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.